Rhythm Pharmaceuticals (RYTM) News Today → Check out WFC chart (From DTI) (Ad) Free RYTM Stock Alerts $41.01 +1.04 (+2.60%) (As of 05:12 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 4:34 AM | marketbeat.comTD Asset Management Inc Invests $1.74 Million in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)TD Asset Management Inc purchased a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 37,800 shares of the company's stock, valued atJune 7 at 6:29 AM | marketbeat.comRafferty Asset Management LLC Has $5.59 Million Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Rafferty Asset Management LLC cut its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 25.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 121,654 shares of the company's stock after selJune 3, 2024 | globenewswire.comRhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024June 3, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 8.2%Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 8.2%June 3, 2024 | globenewswire.comRhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferenceJune 2, 2024 | americanbankingnews.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Rating of "Moderate Buy" from AnalystsMay 30, 2024 | marketbeat.comArtisan Partners Limited Partnership Makes New $12.48 Million Investment in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Artisan Partners Limited Partnership acquired a new position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 271,421 shares of the company's stock, valued at approximately $12,May 27, 2024 | sports.yahoo.comBristol Rhythm conclude homestand with loss to Apotheos FCMay 27, 2024 | msn.comShanghai Disneyland Announces New Musical Stage Show 'The Adventure of Rhythm'May 26, 2024 | marketbeat.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stake Reduced by Clearbridge Investments LLCClearbridge Investments LLC cut its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 50.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 91,158 shares of the companMay 25, 2024 | finance.yahoo.comWhile Rhythm Pharmaceuticals (NASDAQ:RYTM) shareholders have made 125% in 1 year, increasing losses might now be front of mind as stock sheds 3.2% this weekMay 25, 2024 | marketbeat.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA reduced its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,052,648 shares ofMay 22, 2024 | globenewswire.comRhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl SyndromeMay 15, 2024 | finance.yahoo.comRhythm Pharmaceuticals, Inc. (RYTM)May 14, 2024 | insidertrades.comJoseph Shulman Sells 3,984 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) StockMay 14, 2024 | marketbeat.comVictory Capital Management Inc. Buys 162,247 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Victory Capital Management Inc. boosted its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 809.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 182,297 shares of the comMay 13, 2024 | marketbeat.comInsider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 3,984 Shares of StockRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) insider Joseph Shulman sold 3,984 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $38.47, for a total value of $153,264.48. Following the completion of the sale, the insider now directly owns 30 shares of the company's stock, valued at approximately $1,154.10. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.May 9, 2024 | msn.comMario Lemieux Foundation presents AHN with $5 million gift to establish Mario Lemieux Center for Heart Rhythm CareMay 9, 2024 | msn.comLeon Talks Transformative Portrayal of Blues Legend Eddie Taylor in ‘The Rhythm and the Blues’ | EUR ExclusiveMay 9, 2024 | marketbeat.comNational Bank of Canada FI Boosts Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)National Bank of Canada FI lifted its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 82.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 239,000 shares of the compaMay 9, 2024 | msn.comB of A Securities Downgrades Rhythm Pharmaceuticals (RYTM)May 8, 2024 | msn.comSpin Rhythm XD - Official VR & PlayStation Launch TrailerMay 8, 2024 | markets.businessinsider.comSteady Performance and Promising European Growth Justify Buy Rating for Rhythm PharmaceuticalsMay 8, 2024 | markets.businessinsider.comMaintaining Buy Rating on Rhythm Pharmaceuticals: Positive Outlook Amidst Growth and Upcoming CatalystsMay 8, 2024 | finance.yahoo.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Recommendation of "Moderate Buy" from BrokeragesRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the compaMay 8, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $79.00Canaccord Genuity Group reduced their target price on shares of Rhythm Pharmaceuticals from $80.00 to $79.00 and set a "buy" rating for the company in a report on Wednesday.May 8, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Posts Earnings Results, Misses Expectations By $0.01 EPSRhythm Pharmaceuticals (NASDAQ:RYTM - Get Free Report) issued its earnings results on Tuesday. The company reported ($2.35) EPS for the quarter, missing the consensus estimate of ($2.34) by ($0.01). Rhythm Pharmaceuticals had a negative return on equity of 96.02% and a negative net margin of 238.50%. The firm had revenue of $26.00 million during the quarter, compared to analyst estimates of $26.90 million. During the same quarter in the previous year, the business posted ($0.92) EPS. Rhythm Pharmaceuticals's revenue was up 126.1% compared to the same quarter last year.May 8, 2024 | finance.yahoo.comRhythm Pharmaceuticals Inc (RYTM) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...May 8, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Lowered to "Neutral" at Bank of AmericaBank of America cut shares of Rhythm Pharmaceuticals from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $49.00 to $42.00 in a research note on Wednesday.May 8, 2024 | finance.yahoo.comQ1 2024 Rhythm Pharmaceuticals Inc Earnings CallMay 7, 2024 | markets.businessinsider.comBuy Rating Affirmed: Rhythm Pharmaceuticals’ Growth and Clinical Advancements Fuel OptimismMay 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for Rhythm Pharmaceuticals Amid Positive Prescription Growth and Pipeline PotentialMay 7, 2024 | msn.comRYTM Stock Earnings: Rhythm Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024May 7, 2024 | investorplace.comThe 3 Best Nasdaq Stocks to Buy in May 2024May 7, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Given New $46.00 Price Target at Needham & Company LLCNeedham & Company LLC cut their price objective on Rhythm Pharmaceuticals from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday.May 7, 2024 | msn.comMarvelle Healthcare Revolutionizes Hydration with the Debut of Premium Natural Mineral Water Brand, RhythmMay 7, 2024 | msn.comRhythm Pharmaceuticals GAAP EPS of -$2.35 misses by $0.33, revenue of $25.97M misses by $0.93MMay 7, 2024 | finance.yahoo.comRhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst ChallengesMay 7, 2024 | globenewswire.comRhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business UpdateMay 6, 2024 | finance.yahoo.comRhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual MeetingMay 3, 2024 | msn.comAnMed Rhythm on the River in Powdersville postponed: Here's what you need to knowMay 2, 2024 | msn.comCelebrate dance with ‘Rhythm and Joy': A Kathak choreography by Shovana NarayanMay 2, 2024 | msn.comRhythm and Roots Festival's founder, Chuck Wentworth, passes away at 72May 2, 2024 | finance.yahoo.comCardiac Monitoring & Cardiac Rhythm Management Devices Market Worth $26.4 billion | MarketsandMarkets™April 30, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Trading 5.5% Higher Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 5.5%April 30, 2024 | marketbeat.comRhythm Pharmaceuticals (RYTM) Set to Announce Quarterly Earnings on TuesdayRhythm Pharmaceuticals (NASDAQ:RYTM) will be releasing earnings before the market opens on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=589001)April 30, 2024 | yahoo.com'Bigger than the music': Legendary producer of Rhythm & Roots Festival diesApril 29, 2024 | globenewswire.comRhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & EndocrinologyApril 26, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Given Buy Rating at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $50.00 price target on shares of Rhythm Pharmaceuticals in a research note on Friday. Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! RYTM Media Mentions By Week RYTM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RYTM News Sentiment▼0.720.76▲Average Medical News Sentiment RYTM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RYTM Articles This Week▼45▲RYTM Articles Average Week Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arvinas News Today Morphic News Today Akero Therapeutics News Today Pliant Therapeutics News Today Annexon News Today Theravance Biopharma News Today Elanco Animal Health News Today Roivant Sciences News Today Insmed News Today Ascendis Pharma A/S News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RYTM) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on...Paradigm Press | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | Sponsored